In-Vivo Ventures, is an Indiana-based venture capital firm formed in 2003. Its mission is to cultivate and create economic value from the most promising platform technologies emerging from research universities and inventors by seeding each of several new companies with capital, qualified and professional management, and by streamlining the process of licensing and commercializing those technologies. As the Founding Entrepreneur/Management Team, In-vivo Ventures provides a fledgling company with management experienced in both raising capital and starting successful ventures. In-vivo has defined processes that yield solid business strategies, strong corporate structures, and fundable intellectual property. Most importantly, it yields funding structures that provide an inventor with a more equitable stake in the company, and it provides investors and intellectual property licensors with higher returns.

The In-vivo model has proven successful and has the support of some of the finest Midwest research institutions. To date In-vivo has formed Copient Technologies, Inc. (www.copienttech.com), Nuron, LLC (acquired by Intel), Arxan Technologies, Inc. (www.arxan.com), Quadraspec, Inc. (www.quadraspec.com), and Kylin Therapeutics, Inc. (www.kylintherapeutics.com). You may visit In-vivo’s web site at www.in-vivoventures.com.

Golden Pine Ventures, was founded in 2004, in Research Triangle Park, North Carolina. The company’s mission is to aggressively seek out state-of-the-art technologies developed by leading researchers and grow them into substantial businesses that can form the basis of promising biotechnology and biomedical companies. Golden Pine Ventures specializes in finding the truly revolutionary technologies, the rare “golden pines” in the evergreen forest of the technology world. The management and directors of Golden Pine Ventures have a history of past successful ventures in the biotechnology field. In total, they have successfully launched over two dozen companies, raised over a billion dollars for portfolio companies, and have taken seven of these companies public. You may visit Golden Pine’s website at www.goldenpineventures.com.